Alexion Pharmaceuticals
Headquartered in Cheshire, Connecticut (USA), Alexion is global biopharmaceutical company focused on the development and delivery of life-transforming therapies for patients with severe and life-threatening rare disorders.
Financial Data
-
31st Dec 16 Source: Estimated
- €188.1 million turnover
- 500 employees
-
31st Dec 15 Source: Estimated
- €152.1 million turnover
- 200 employees
- 2 more years available »
Ranking
By Turnover
(€188.1 million)- 313th in Top Companies
- 38th in Health
- 39th in Pharma
By Employees
(500)- 345th in Top Companies
- 55th in Health
- 33rd in Pharma
- 500
- €188.1 million
Employees
- Julie O'Neill Senior vice president